Cancer

207 Items

All Items

The relationship between tumor budding and survival of patients with breast cancer: A meta-analysis

Hongjie Xu, Dajun Wei
F13B regulates angiogenesis and tumor progression in hepatocellular carcinoma via the HIF-1α/VEGF pathway

Dong Jiang, Zhi Qi, Zhi-ying Xu, Yi-ran Li
VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating UBR5 mRNA and m6A levels

Chunyu Zhu, Yameng Cheng, Yao Yu, Yanning Zhang, Guiyun Ren

1244–1257
Clinical diagnostic value of contrast-enhanced ultrasound combined with microflow imaging in benign and malignant renal tumors: A retrospective cohort study

Xiufeng Kuang, Huiyang Wang, Weilu Chai, Huafang Yuan, Ting He, Mengya Shi, Tianan Jiang

1370–1379
SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of S100A16 and activation of the PI3K/AKT signaling pathway

Hang Jiang, Zhiqian Xue, Liping Zhao, Boyuan Wang, Chenfei Wang, Haihan Song, Jianjun Sun

1231–1243
Tumor-type agnostic, targeted therapies make a new step forward: The first tumor-agnostic approval of a HER2-targeted therapy

Semir Vranic, Zoran Gatalica

673–675
Cuproptosis-related gene LIPT1 as a prognostic indicator in non-small cell lung cancer: Functional involvement and regulation of ATOX1 expression

Ruiyun Deng, Lili Zhu, Jun Jiang, Jing Chen, Hua Li

647–658
Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells

Huimin Li, Xiyu Tang, Zhiwei Sun, Zhongyuan Qu, Xiang Zou

560–574
The prognostic role of the change in albumin-derived neutrophil-to-lymphocyte ratio during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

Zhen Pan, Ye Wang, Shoufeng Li, Huajun Cai, Guoxian Guan

612–624
Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study

Zhenchi Li, Zhibin Xu, Jiangping Wang, Mei Wang

633–646
Nuclear factor erythroid 2-related factor 2 promotes radioresistance by regulating glutamate-cysteine ligase modifier subunit and its unique immunoinvasive pattern

Zhaoyuan Xue, Yiliyaer Nuerrula, Yilidana Sitiwaerdi, Mayinur Eli

545–559
Progress of lymphocyte activation gene 3 and programmed cell death protein 1 antibodies for cancer treatment: A review

Yu-Quan Li, Xue-Mei Chen, Gui-Fei Si, Xue-Min Yuan

764-774
Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab

Hasan Cagri Yildirim, Hicran Anik, Deniz Ates Ozdemir, Rashad Ismayilov, Arif Akyildiz, Kerim Cayiroz, Fahri Ceyhan, Oguzalp Kavruk, Deniz Can Guven, Ozturk Ates, Alp Usubutun, Zafer Arik

998-1003
GATA2 mutant variant allele frequency may reflect prognosis in Chinese adult patients with de novo cytogenetically normal acute myeloid leukemia

Huanying Ren, Minglin Hong, Jingyi Feng, Zhuanghui Hao, Xian Chen, Fengting Liang, Wei Wei, Xuelan Liang, Hongwei Wang, Xiuhua Chen

982-989
Leukotriene B4 receptor knockdown affects PI3K/AKT/mTOR signaling and apoptotic responses in colorectal cancer

Cui Tang, Aili Wang, YanLin Zhao, WenYing Mou, Jun Jiang, Jie Kuang, Bin Sun, Erjiang Tang

968-981
CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer

Weidan Fang, Dewen Wan, Yi Yu, Ling Zhang

101–124
Clinical features and demographic characteristics of gestational trophoblastic neoplasia: Single center experience and the SEER database

Yue-min Hou, Pei-pei Li, Hui Yu, Fang Feng, Xin-yi He, Bi-han Chen, Jia-ling Li, Hao-yan Yao, Rui-fang An

176–187
Cell division cycle 42 effector protein 4 inhibits prostate cancer progression by suppressing ERK signaling pathway

Xiaowen Zhang, Tao Yu, Guojun Gao, Junbao Xu, Ruihui Lin, Zhifang Pan, Jianying Liu, Weiguo Feng

840-847
Comparison of the clinical features and long-term prognosis of gallbladder neuroendocrine carcinoma versus gallbladder adenocarcinoma: A propensity score-matched analysis

Ya-Fei Hu, Wen-Jie Ma, Hai-Jie Hu, Han-Fei Gu, Yan-Wen Jin, Fu-Yu Li

1096–1107
$Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study$

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study

Sabin Goktas Aydin, Engin Eren Kavak, Atakan Topcu, Ayberk Bayramgil, Fahri Akgul, Seda Kahraman, Musa Baris Aykan, Yunus Emre Altıntas, Kaan Helvaci, Yuksel Urun, Ahmet Bilici, Mesut Seker, Mehmet Ali Nahit Sendur, Omer Fatih Olmez, Ozgur Acikgoz, Irfan Cicin

1089–1095

1-20 of 207 Next